Collegium Pharmaceutical Inc expected to post earnings of 52  cents a share - Earnings Preview

Collegium Pharmaceutical

04/11/2023 03:05

* Collegium Pharmaceutical Inc  COLL.OQ   COLL.O  is
expected
to show a rise in quarterly revenue when it reports  results 
    * The Stoughton Massachusetts-based  company is expected to
report
 a 9.1% increase in revenue to $138.528 million from $127.01
million a year ago, according to the mean estimate from 6
analysts, based on LSEG data. 
    * ​Refinitiv's mean analyst estimate for Collegium
Pharmaceutical
Inc is for earnings of 52 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Collegium
Pharmaceutical Inc is $33.5​, above​ its last closing price
of $22.20. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  0.28        0.29       0.34      Beat    18.3
 Mar. 31 2023  0.26        0.31       -0.51     Missed  -262.4
 Dec. 31 2022  -0.04       -0.14      -0.21     Missed  -44.8​
 Sep. 30 2022  -0.19       -0.13      0.01      Beat    107.4
 ​​Jun.        1.38        1.42       0.32      Missed  -77.5
 30 2022                                                
 Mar. 31 2022  0.90        0.90       0.44      Missed  -50.9​
 Dec. 31 2021  1.06        1.04       -0.51     Missed  -149.2
 Sep. 30 2021  0.95        0.95       0.22      Missed  -76.9
 This summary was machine generated November 4 at 03:05 GMT.  All
figures in US dollars  unless otherwise stated